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SUMMARY 
Background: To determine the prevalence of Peripheral Arterial Disease (PAD) and associated risk factors in pa-
tients undergoing amputation at the Korle Bu Teaching Hospital (KBTH), Accra, Ghana. 
Objectives: A cross- sectional study of all patients undergoing lower extremity amputation at the Department of 
Surgery, KBTH. 
Materials: A coded questionnaire was used to ascertain risk factors for PAD. The Edinburgh Claudication Question-
naire was used to determine symptomatic PAD and a 5 mmHz hand held Summit® Doppler together with an Ac-
coson® sphygmomanometer was used to determine PAD and its severity. 
Method: Clinical diagnosis of symptomatic PAD was made using a symptom-based questionnaire and signs of PAD 
determined by measuring the ankle brachial pressure index (ABPI) by means of a handheld Doppler and sphygmo-
manometer. Risk factors were determined using the coded questionnaire and related to the occurrence and severity 
of PAD. 
Results: The prevalence of PAD among recruited participants was 71%. Twenty-eight per cent of participants with 
PAD in the index limb also showed signs of PAD in the other limb. The diagnosis of PAD was made in 71%, using 
ABPI, and 13%, using ECQ. Twenty-seven per cent of patient with hypertension, seventeen per cent with diabetes 
and all patients with hypercholesterolemia were not on any form of medication. 
Conclusion: There is a high prevalence of PAD among patients undergoing lower extremity amputation at the 
KBTH. The majority of PAD patients presented with moderate to severe PAD. Instituting measures to identify and 
control risk factors of PAD may reduce this high burden. 
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INTRODUCTION 
Peripheral arterial disease (PAD) is an atherothrombotic 
syndrome marked by stenosis and occlusion of periph-
eral arterial beds. The target organs are the brain, heart, 
intestine, kidneys and the limbs, typically the lower 
extremities. 
 
It affects 12-14% of the general population and the 
prevalence is age dependent.1-3 Within one year of 
presentation with severe leg ischemia, 30% of patients 
undergo a major amputation and 25% die of PAD.4 
Globally, a majority of patients are asymptomatic and 
undiagnosed until the disease has progressed to a late 
stage, requiring limb amputation. Worldwide, the preva-
lence of asymptomatic PAD ranges between 3-10% and 
that of symptomatic PAD is 3% for patients in their 40s 
and 6% for patients in their 60s.4 Symptoms range from 
intermittent claudication and leg numbness to ischemia 
requiring amputations. However, given the large num-
ber of asymptomatic PAD, clinical history has a low 
sensitivity for determining the presence of PAD. Risk 
factors for development and progression of PAD in-
clude smoking, hypertension, diabetes, hypercholester-
olemia and physical inactivity. Successful treatment 
strategies of PAD include risk factor modification such 
as cessation of smoking and initiation of regular exer-
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use of antiplatelet agents to reduce risk of atherothrom-
botic events.5-8  
 
Vascular disease accounts for 8.6% of major amputation 
after diabetic foot complications (41.9%) and trauma 
(38.4%).9 In patients with critical limb ischemia who do 
not have revascularization options, major amputation is 
required within 1 year in as many as 40% of patients.10 
There has been a wide variation in reports of the preva-
lence of PAD from Sub-Saharan Africa. The prevalence 
has ranged from a low 1.7% in Central Africa to a high 
28% in Dakar.7 Previous studies from Ghana have re-
ported a PAD prevalence of 1%.12  
 
There is an apparent lack of interventional procedures 
for patients with PAD in developing countries, and in 
many instances, the disease progresses to limb ischemia 
requiring amputation. The social and economic implica-
tions for patients who have amputations in the develop-
ing countries are enormous. The lack of adequate reha-
bilitation facilities and poor prosthetic services implies 
that amputees are often discharged from hospital with 
no programs for re-training.  The cost of prostheses is 
also beyond the means of most patients who have un-
dergone amputation in local hospitals and as such many 
of them are condemned to a wheelchair, crutches or are 
bed-ridden at home.13 
 
Despite the recognition of PAD as a major thrombotic 
risk factor, its occurrence and burden are not sufficient-
ly appreciated by clinicians, and most cases are undiag-
nosed. Increased awareness about PAD and benefits of 
risk factor reduction could potentially lead to a decrease 
in the disease burden. There is a paucity of data on the 
prevalence or incidence of PAD in Korle Bu Teaching 
Hospital (KBTH) and institutional protocols for treat-
ment of PAD are lacking. This study determined the 
prevalence and severity of PAD and the associated risk 
factors in patients undergoing amputation at the KBTH. 
The study also evaluated the use of ankle brachial pres-
sure index (ABPI) in the diagnosis of PAD.  
 
METHODS 
This was a cross-sectional study in the Department of 
Surgery in Korle Bu Teaching Hospital. The Korle Bu 
Teaching Hospital is the leading referral centre in Gha-
na and the third largest hospital in Africa. It has over 
2000 beds, 21 clinical and diagnostic departments and 
an average daily attendance of 1500 patients with about 
250 admissions.14 All patients undergoing lower extrem-
ity amputation from September 2013 to August 2014, 
were enrolled with the study. At the end of each day, 
patients admitted for amputation on each of the general 
surgical wards were recruited and their diagnosis and 
the procedures they were to undergo was confirmed by 
the Principal Investigator. The rationale for the study 
was explained in detail to the patients and an informed 
written consent was obtained.   
 
A coded questionnaire was administered to consenting 
patients. The questionnaire sought to obtain information 
on demographic characteristics, reason for amputation, 
relevant clinical information including history of previ-
ous amputations and assess risk factors of PAD. The 
Edinburgh Claudication Questionnaire15 was used to 
diagnose symptomatic PAD. The ABPI was measured 
using a 5 millimeter Hertz (mmHz) hand held Summit® 
Doppler to obtain systolic pressures in both right and 
left brachial and posterior tibial arteries. Each systolic 
pressure was measured twice, with an Accoson® 
sphygmomanometer (AC Cossor & Son (Surgical) Ltd, 
Harlow, Essex CM19, 5QP). The ABPI was calculated 
by dividing the mean posterior tibial pressure in each 
leg by the mean of the brachial pressures. Their blood 
pressures were measured using an Accoson® sphygmo-
manometer and recorded in millimetres of mercury 
(mmHg). 
 
Peripheral arterial disease and its severity was defined 
using the American Diabetes Association consensus 
paper which quotes 0.91-1.3 as the normal range of 
ABPI.16 Mild PAD have ABPIs of 0.7-0.9, moderate 
PAD range between 0.41 and 0.69 and ratios of less 
than or equal to 0.4 are quoted for severe disease. The 
fasting blood sugar of each subject was measured using 
a Contour® glucometer and Contour® blood glucose test 
strips (Bayer Healthcare LLC, Mishawaka IN 46544, 
USA) and recorded in grams per decilitre (g/dl). 
 
Blood samples (5mls) were drawn at 6am, after 8 hours 
of overnight fast, from all subjects to assess their lipid 
profile. The lipid profile was determined by means of an 
automated clinical chemistry analyser (Rz Monza Ran-
dox Laboratories Ltd UK). Lipid profile was recorded in 
millimoles per litre (mmol/L). 
 
Stata, version 13 was used to analyse the data. Descrip-
tive statistics were determined for all quantitative varia-
bles. Cross tabulation of continuous variables and asso-
ciation tests for data was analysed using correlation 
analysis. Regression analysis was used to investigate 
relationship between PAD and risk factors. The level of 
significance used was 0.05. Ethical approval was sort 
from the Ethical and Review Committee of the School 
of Medicine and Dentistry, University of Ghana (Proto-
col Identification Number: MS-Et/M.7 – P 4.8/2012-
13).All participants signed a written informed consent 
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RESULTS 
A total of 76 patients were recruited over the period 
with a mean age of 65years. Forty-seven per cent (36) 
of patients were elderly (age >65) with a female: male 
ratio of 1.45:1. Thirty-six (47.4%) patients were admit-
ted for amputation on account of a wet gangrene whilst 
forty (52.6%) were due to dry gangrene of the affected 
leg (Table 1). Other baseline demographic parameters of 
recruited participants are summarized in Table 1. Forty 
(52.6%) patients were known hypertensive (Table 1). 
Eleven (27.5%) of these patients were not on any form 
of medication and one patient had had a cerebrovascular 
accident 20 years earlier. The systolic blood pressures 
measured was higher than 140mmHg in 35 participants, 
14 of whom were not known to be hypertensive. 
 
Fifty-seven (75%) of the patients were known diabetic 
(Table 1), 10 (17.5%) of whom were not on any form of 
medication. The fasting blood sugars were above the 
upper limit of 6.0mmol/L in 48(84.2%) patients who 
were known diabetics. Thirty-nine (51%) of the patients 
were known to be both hypertensive and diabetic. Five 
(6.6%) patients had been previously diagnosed with 
hypercholesterolemia and were on lipid lowering drugs. 
From the lipid profiles, seven (9.2%) had hypercholes-
terolemia, but none were on lipid lowering drugs.  
Using the Edinburgh Claudication Questionnaire 
(ECQ), 14 (18%) patients were diagnosed with PAD, 34 
(45%) patients had no PAD symptoms and symptoms 
could not be assessed for 28 (37%) patients because 
they were unable to walk because of a previous cere-
brovascular accident, previous amputation or were gen-
erally weak due to old age (Table 2). 
 
Using the ABPI, fifty-four (71%) patients were diag-
nosed with PAD of the index limb (Table 2). Of these, 
32 (59.3%), 12 (22.2%), and 10 (18.5%) patients had 
severe, moderate and mild PAD, respectively. PAD of 
the index limb could not be assessed in 1 patient admit-
ted for an above knee amputation because he had had 
previous below knee amputation. 
 
Using the ABPI, 21 (28%) patients already showed 
signs of PAD of the other lower limb (Table 2): 5 with 
moderate disease and 16 with mild disease. Of the pa-
tients diagnosed with PAD, 29 (53.7%) were hyperten-
sive, 39 (72.2%) patients had diabetes and 5 (9.3%) had 
hypercholesterolemia. Seven patients had high triglycer-
ide levels, 5 had high HDL levels, 34 had low levels of 
HDL and 8 patients had high LDL levels. Ten (18.5%) 
of these patients smoked and only 15 (27.8%) exercised 
(Table 1). 
 
Table 1 Baseline characteristics and Factors affecting Peripheral Arterial Disease 
Characteristics/Factor  Number 
(%) 
(N=76) 
Number with Peripheral 
Arterial Disease (%) 
(n-54) 
Severity of Peripheral Arterial Disease 
Mild (%)  Moderate (%)  Severe (%) 
(0.7-0.9)       (0.4-0.69)          (0.0.4) 














5                      6                        18 
2                      6                        12 











4                     3                         13 














1                      1                        7 
1                      8                        13 
8                      3                        12 
Diabetes mellitus 57 (75) 39 (72.2) 9                     10                       20 
Hypertension 40 (52.6) 29 (53.7) 4                      6                        19 
Hyperlipidemia 5 (6.6) 5 (9.3) 3                      1                         1 
Smoking 12 (15.8) 10 (18.5) 2                      1                         7 
Exercise 23 (30.3) 15 (27.8) 3                     4                          8 










10                     12                     29 
-                -                        3 










9                      5                        6 
1                      7                        26 
Type of amputation 















5                     3                         20 
2               6                         10 
-                      -                          - 
3                      3                          2 
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Table 2 Presence of PAD using Edinburgh claudication questionnaire (ECQ) or Ankle Brachial Pressure Index 
(ABPI) 
 Symptomatic PAD (%) 
ECQ 
Clinical PAD (%) 
ABPI 
Severity of PAD (ABPI) 
Peripheral Arterial Disease 
(PAD) of Index limb 
Present 
Absent 











Mild (%)  Moderate (%)  Severe (%) 
(0.7-0.9)       (0.4-0.69)          (0.0.4) 
 
10 (13.6)     12 (15.79)         32 (42.11) 
 
 
Peripheral Arterial Disease 
(PAD) of Other limb 
Present 
Absent 











Mild (%)  Moderate (%)  Severe (%) 
(0.7-0.9)       (0.4-0.69)          (0.0.4) 
 




Univariate and multivariate analysis of the baseline de-
mographic and clinical characteristics of the patients 
including age, gender, diabetes, hypertension, hypercho-
lesterolemia, smoking and exercising showed no rela-
tionship with PAD (OR >1 for all comparisons) (Table 
3). 
 
Table 3 Measured values of selected clinical and lbora-
tory parameters for patients undergoing lower limb am-
putation in KBTH. 
Variable  Result 
ABPI; Index limb, mean (sd) 0.54 (0.46) 
ABPI; Other limb, mean (sd) 1.00 (0.29) 
Systolic BP in mmHg, median (range) 136 (100 – 180) 
 FBS, median (range) 7.4 (2.72 – 22.6) 
Serum cholesterol, median (range) 2.94 (0.23 – 19.83) 
Triglycerides, mean (sd) 1.42 (0.73) 
HDL, median (range) 0.84 (0.06 – 10.07) 
LDL, median (range) 1.59 (0.00 – 8.41) 
VLDL, median (range) 0.55 (0.51 – 5.00) 




The prevalence of peripheral arterial disease in patients 
undergoing lower limb amputation in KBTH (71.1%) 
was high. The high prevalence rate in this study is due 
to the subject population of patients undergoing amputa-
tion. Limb salvage procedures, which are almost non-
existent in our facility, attempted before admission for 
amputation was captured in this study. The lack of so-
phisticated methods of diagnosis and treatment in Gha-
na, lack of awareness of our people and late presentation 
means that many limbs that could be salvaged will con-
tinue to be lost.13 The Edinburgh Claudication Ques-
tionnaire15 was used to diagnose symptomatic PAD. 
However, ninety per cent (90%) of patients with asymp-
tomatic PAD would be missed if a complaint of inter-
mittent claudication was to be used in diagnosis.17, 18 In 
this study, only 18.4% (14) of patients were diagnosed 
with PAD using the ECQ, thus missing the diagnosis in 
39.5% (30) of the patients. 
ABPI is considered a reliable method for diagnosing 
symptomatic and non-symptomatic PAD.19, 20 Seventy-
one per cent (54) of patients were diagnosed with PAD 
using the ABPI in this study. The American Diabetes 
Association consensus paper quotes 0.91-1.3 as the 
normal range of ABPI.16 This same consensus paper 
states that patients with mild disease have ABPIs of 0.7-
0.9, whilst those with moderate ischemia have ratios of 
between 0.41 and 0.69. Patients with mild or moderate 
disease will be claudicants. Ratios of less than or equal 
to 0.4 are quoted for severe disease, and affected pa-
tients present clinically with critical limb ischemia. 
 
A worrying trend noted in this study was that, of the 
forty patients who were known to be hypertensive, 
27.5% were not on any form of medication. Also 17.5% 
of patients known to have diabetes were not on any 
form of medication and none of the patients with lipid 
profiles indicating hypercholesterolemia were on lipid 
lowering drugs. Controlling hypertension adequately 
reduces cardiovascular mortality in persons with PAD.8, 
21 and treatment of dyslipidaemia with statins has been 
documented to reduce the incidence of mortality, cardi-
ovascular events and stroke in persons with PAD.7, 22-24 
Statins significantly reduce the incidence of intermittent 
claudication by 35%.7 Elderly persons with PAD and 
hypercholesterolemia should be treated with statins to 
reduce cardiovascular mortality and morbidity and pro-
gression of PAD7, 22-25 and to improve exercise time un-
til claudication.  
 
Risk factor modification such as cessation of smoking 
and initiation of regular exercise reduces the risk of ath-
erothrombotic events. Continuing smoking increases 
risk of amputation in patients with intermittent claudica-
tion.6 Cessation of smoking decreases progression of 
PAD to critical leg ischemia.5The low rate of smoking 
recorded among patients in this study is consistent with 
the reported low prevalence of smoking in Ghana.26 Ten 
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Only 30% (23) of the patients engaged in some form of 
exercise. However, 15 (65%) of the exercising group 
had PAD. Walking exercise in patients with PAD pro-
longs the onset of claudication pain thus allowing the 
patient to walk longer but does not change the ABPI.27-
29 Supervised exercised training is recommended for a 
minimum of 30-45minutes in sessions performed at 
least three times per week for a minimum of 12weeks 
and preferably for six months or longer.30, 31 Strength 
training is less effective than treadmill walking.32 The 
lack of association between these known risk factors 
and PAD in this study could be due to to lack of statisti-
cal power or dilution of effect since the majority of di-
agnosed PAD was moderate-to-severe and the incidence 
of diabetes and hypertension were high.”.Twenty-eight 
per cent of patients already showed signs of peripheral 
arterial disease of the other lower limb. Steps can be 
taken to halt or drastically reduce the progress rate of 
PAD in these patients such as controlling diabetes, hy-
pertension, hypercholesterolemia as well as cessation of 
smoking, even in the low number of participants engag-
ing in this risk factor and also encouraging exercises. 
 
Endovascular approach is advocated in all PAD33 and 
could have been considered in our patients especially 
those who had mild and moderate PAD instead of am-
putation. Endovascular interventions in patients with 
chronic limb ischemia can result in limb salvage though 
they have a high likelihood of repeat interventions to 
maintain patency.34 Indications for lower extremity in-
traluminal angioplasty, endarterectomy or bypass sur-
gery are (1) incapacitating claudication in persons inter-
fering with work or lifestyle, (2) limb salvage in persons 
with limb-threatening ischemia as manifested by rest 
pain, non-healing ulcers, and/or gangrene and (3) vascu-
logenic impotence.35 
 
Percutaneous balloon angioplasty and/or stenting is in-
dicated for short-segment stenosis, whereas mul-
tisegment disease and occlusions are most effectively 
treated with surgical revascularization.36 Revasculariza-
tion should be considered to improve symptoms of pa-
tients with intermittent claudication31 and should be 
considered in our patients who are showing signs of 
peripheral arterial disease in their other limb. Increased 
awareness among members of our health care communi-
ty about the prevalence of peripheral arterial disease and 
benefits associated with risk-factor reduction should 
produce substantial decrease in the burden of this dis-
ease. Intensive educational programs are needed to edu-
cate physicians to use lipid lowering therapy in elderly 





There is a high prevalence of PAD among patients un-
dergoing lower extremity amputation at the KBTH, ma-
jority presenting with moderate to severe PAD. The 
ECQ may not be the best tool to adapt to diagnose early 
PAD in our part of the world hence periodically measur-
ing the ABPI of patients at risk of PAD may be better 
with early diagnosis of PAD.  Further studies are sug-
gested in a more general population to find the preva-
lence of PAD. 
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